IVI and Lemonex sign MOU to join forces on vaccine development

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

The International Vaccine Institute announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development.

Dogs are a better proxy for human health risks, UQ researchers say

Previous article

Gen Z takes control of its future

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News